LSP extends its portfolio in medical devices and invests in Simplify Medical



Amsterdam, the Netherlands - 20 July 2017 - LSP (Life Sciences Partners) announces its investment in Simplify Medical. Simplify Medical is focused on cervical spinal disc arthroplasty, using innovative, MRI-friendly materials designed to decrease the need for ionizing radiation and enhance patient options. The Simplify Disc has received the CE Mark and has been used to treat more than 700 patients outside the U.S. over the last three years. Simplify Medical is located in Sunnyvale, California (USA).
 
The press release of Simplify van be found here.  
 
About LSP
LSP is an independent European investment firm, providing financing for private and public life sciences companies. LSP’s mission is to connect investors to inventors, focusing on unmet medical needs. Since the late 1980s, LSP’s management has invested in about 100 innovative enterprises, many of which have grown to become leaders of the global life sciences industry. With over €1 billion of investment capital raised to date and offices in Amsterdam, Munich and Boston, LSP is one of Europe’s leading life sciences investors. For more information, please visit www.lspvc.com.
 
Contact:
Dr F. Azzam
Partner LSP
snmmnz@yfcip.pbz
 
« back to overview
Follow us

LSP extends its portfolio in medical devices and invests in Simplify Medical



Amsterdam, the Netherlands - 20 July 2017 - LSP (Life Sciences Partners) announces its investment in Simplify Medical. Simplify Medical is focused on cervical spinal disc arthroplasty, using innovative, MRI-friendly materials designed to decrease the need for ionizing radiation and enhance patient options. The Simplify Disc has received the CE Mark and has been used to treat more than 700 patients outside the U.S. over the last three years. Simplify Medical is located in Sunnyvale, California (USA).
 
The press release of Simplify van be found here.  
 
About LSP
LSP is an independent European investment firm, providing financing for private and public life sciences companies. LSP’s mission is to connect investors to inventors, focusing on unmet medical needs. Since the late 1980s, LSP’s management has invested in about 100 innovative enterprises, many of which have grown to become leaders of the global life sciences industry. With over €1 billion of investment capital raised to date and offices in Amsterdam, Munich and Boston, LSP is one of Europe’s leading life sciences investors. For more information, please visit www.lspvc.com.
 
Contact:
Dr F. Azzam
Partner LSP
snmmnz@yfcip.pbz
 
« back to overview